Erector Spinae Plane (ESP) Block for Renal Colic

June 1, 2026 updated by: Michael Secko, MD, Stony Brook University

Can Erector Spinae Plane (ESP) Block Better Relieve Acute Renal Colic Pain Than Standard of Care

Comparing standard of care to erector spinae plane block for acute renal colic pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Will compare at times 0, 10 minute, 20 minute, 40 minute and 60 minutes after local nerve block given.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • Stony Brook, New York, United States, 11794
        • StonyBrook University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 to 65 years old
  • ASA Level I and II
  • flank pain concerning for renal colic in ED

Exclusion Criteria:

  • pregnant women
  • subjects unable to appreciate ESP block landmarks under ultrasound
  • skin infection over needle site insertion
  • Allergy to local anesthesia (lidocaine/Ropivacaine)
  • bleeding disorders
  • serious cardiac, lung, liver or kidney dysfunction
  • history of spine surgery
  • history of spinal infection
  • history of epidural injection within 6 months
  • acute exacerbation of serious mental disease
  • unable to consent
  • unable to communicate pain level

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: ESP Nerve Block for Renal colic
On top of receiving standard of care, At T8 nerve level, with ultrasound guidance to bathe the nerve
Drug: Ropivacaine injection
Local anesthesia injected under ultrasound guidance
Active Comparator: Standard of care
Whatever medications the clinician normally treats renal colic with
Other: Standard of care medications
Whatever the ED clinicians normally give for renal colic pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baseline Pain before intervention
Time Frame: Before the ESP Block
Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain"
Before the ESP Block
Pain score at 10 minutes
Time Frame: 10 minutes after the ESP Block
Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain"
10 minutes after the ESP Block
Pain score at 20 minutes
Time Frame: 20 minutes after ESP Block
Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain"
20 minutes after ESP Block
Pain score at 40 minutes
Time Frame: 40 minutes after ESP Block
Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain
40 minutes after ESP Block
Pain score at 60 minutes
Time Frame: 60 minutes after ESP Block
Using the Visual Analog Scale for Pain Assessment Tool with 0 meaning "No pain" and 10 meaning "Unbearable Pain
60 minutes after ESP Block

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Need for extra opiates
Time Frame: Starting from time 0 after the ESP Block intervention completed till discharge or urology intervention
Record how much opioids patients receives starting after the ESP Block for both the "standard of care" patients and the ESP Block group
Starting from time 0 after the ESP Block intervention completed till discharge or urology intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Stony Brook University

Investigators

  • Principal Investigator: Michael Secko, MD, StonyBrook University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 25, 2022

Primary Completion (Actual)

January 9, 2026

Study Completion (Actual)

January 9, 2026

Study Registration Dates

First Submitted

October 8, 2021

First Submitted That Met QC Criteria

April 11, 2022

First Posted (Actual)

April 12, 2022

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB2021-00518

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Colic

Clinical Trials on Ropivacaine injection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe